This algorithm generates tumors to help fight cancer
Researchers have built a system to create a larger and more diverse data set on which to train medical AI.
You’re only as effective as your data set: Most artificial-intelligence programs rely on a large set of information to learn from. But if the data isn’t representative of all populations or circumstances, the system could be biased or ineffective.
The news: A new study out from chip company Nvidia, the Mayo Clinic, and the MGH & BWH Center for Clinical Data Science has created an algorithm that produces a more diverse set of medical data. Using generative adversarial networks (or GANs), synthetic scans depicting abnormalities can be created from existing MRIs of brain tumors.
Why it matters: “Diversity is critical to success when training neural networks, but medical imaging data is usually imbalanced,” Hoo Chang Shin, a research scientist at Nvidia, told ZDNet. “There are so many more normal cases than abnormal cases, when abnormal cases are what we care about, to try to detect and diagnose.”
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.